Mission
The goal of UniMS is to provide state-of-the-art MS services to the scientific community and Industry, guaranteed by the continuing increase in Mass Spectrometry know-how and infrastructures within our unit.
The increasing complexity of biologics and their use in clinical trials poses critical challenges regarding their quality, safety, and efficacy requirements. This has driven the demand for advanced analytical methodologies that offer high resolution, sensitivity, and time/cost-effectiveness.
Mass Spectrometry Unit (UniMS), provides specialized analytical support to internal R&D projects, as well as to various partners in academia and industry.
Applying a comprehensive suite of advanced bioanalytical tools, UniMS performs analysis of complex biologics, including antibodies, recombinant proteins, antibody-drug conjugates, virus and ATMPs for gene/cell-based therapies.
We are committed to delivering high-quality, reliable data that enables specific and accurate characterization of diverse biomolecules and bioprocesses. This is achieved through tailored approaches, where our UniMS team works closely with partners to apply in-house available methodologies or develop customized analytical methods to address the unique challenges of each R&D project.
Our range of analyses focuses on Proteomics & Biologics Characterization and Metabolomics.
